Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Biomarkers, breast density and risk reduction perspectives in BRCA carriers.

Trial Profile

Biomarkers, breast density and risk reduction perspectives in BRCA carriers.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2018

At a glance

  • Drugs Deslorelin (Primary) ; Estradiol (Primary) ; Testosterone (Primary)
  • Indications Breast cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 25 Jul 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
    • 25 Jul 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top